The tape just handed you a signal on a tech-enabled pharmacy play, with a heavy-volume move higher pointing to something building beneath the surface.
Read this, and you can follow the trend in a business that long-term care facilities are quietly starting to depend on.
Safe Haven (Sponsored)
It’s been two weeks since Operation Epic Fury began—has anything actually calmed down?
If anything, tensions are rising, with continued airstrikes, missile launches, and pressure on key oil routes like the Strait of Hormuz. Gas prices are already climbing, and prolonged disruption could push inflation even higher.
If your savings are tied to stocks or bonds, your portfolio may be exposed if this escalates. That’s one reason many Americans turn to physical gold during times of conflict and uncertainty.
Red State Gold Group’s FREE Gold IRA Guide explains how eligible retirement funds can be moved into gold and silver.
Claim your free guide
Or call (888) 711-2433 to speak with a U.S.-based specialist.
Healthcare
Long-Term Care Pharmacy Just Dispensed A Session Worth Paying Attention To
Guardian Pharmacy Services (NYSE: GRDN) just had a sharp session backed by heavier-than-usual volume, and that combination tends to signal interest building in a more meaningful way rather than a random pop. The business behind the move is what makes it worth sitting with.
GRDN is building a more integrated, technology-enabled model that long-term care facilities are starting to lean on for efficiency and better patient outcomes. When both price action and the underlying story are pointing in the same direction at the same time, you want to keep watching rather than scrolling past.
Tech-Enabled Model Is Separating This Pharmacy From Traditional Peers
Integrated platforms and data tools are becoming central to how services are delivered and optimized in long-term care settings. That edge compounds over time as more facilities prioritize measurable outcomes and operational efficiency over the old way of doing things.
Buying Activity And Improving Outlook
When volume picks up alongside a stronger forward outlook, the trend tends to hold longer than it does without that confirmation. You are watching a setup where momentum and expectations are both reading from the same page, and that alignment tends to keep a name relevant rather than fading it.
Technology
Electronics Supply Chain Name Picking Up Steam As Demand Stabilizes
Avnet (NASDAQ: AVT) is back on the radar and doing enough of the right things to stay in the conversation. The business sits at the center of the global electronics supply chain, connecting manufacturers, resellers, and system builders in a role that becomes increasingly valuable as demand cycles start to stabilize again. That is exactly the environment starting to take shape.
What is worth tracking is how earnings expectations are beginning to shift alongside price action that has been controlled and gradual rather than explosive. This is not yet a high-conviction name, but the combination of improving estimates and steady momentum creates a setup that rewards attention rather than action taken in haste.
Momentum Is Building
The shift in sentiment here is gradual, and that is actually what makes it interesting. Consistent upward movement in estimates tends to reflect growing confidence in the underlying business, and when that happens slowly, it tends to stick longer than a sharp revision cycle.
Supply Chain Positioning Gets More Valuable
Sitting at the center of the electronics ecosystem gives Avnet real leverage when conditions improve. As hardware demand finds firmer footing, that positioning translates into more predictable revenue and better visibility across the business.
Plan Smart (Sponsored)
Experienced investors don’t wait for problems—they prepare early.
Rising debt, persistent inflation, and constant intervention are already eroding purchasing power.
Gold has held value for centuries because it isn’t tied to policy or confidence.
More savers are turning to physical gold through self-directed IRAs.
Click here to get Priority Gold’s FREE Kit and learn how it works.
Healthcare
Earnings Upgrade Just Put This Biotech Name Back On The Radar Hard
Agenus (NASDAQ: AGEN) is back in focus after a notable upgrade to its earnings outlook, and this is not the kind of shift that shows up for no reason. When estimates start moving higher, it tends to reflect real growing confidence in the business direction, and that kind of change often carries more weight for price than a single headline ever does.
The direction of revisions is what you want to track here. Consistent upward adjustments signal that the people modeling this business are seeing something worth recalibrating for, and those adjustments tend to build on each other rather than happening in isolation.
Reshaping How This Name Gets Looked At
Consistent upward revisions tend to shift how a stock is positioned over shorter timeframes. When you see the direction stay consistent rather than flip back and forth, it usually reflects something tangible happening inside the business rather than just analyst optimism running hot.
Sustained Revision Trend
When expectations keep moving in the same direction, it tends to reinforce conviction rather than shake it. That backdrop can attract sustained interest rather than the kind of attention that spikes once and moves on, and that is exactly the kind of setup worth holding on your watchlist.
Actionable Picks This Week
Strategic Education (NASDAQ: STRA) is drawing renewed interest after improved earnings outlooks and a steady value profile that keeps the setup grounded.
A forward multiple that looks reasonable relative to cash flow, combined with consistent upward estimate revisions, gives you the kind of mix that tends to attract attention when markets rotate toward quality.
The business benefits from steady demand in education services and a diversified academic platform that helps absorb volatility across the sector.
As expectations continue improving, the stock stays positioned to respond if the trend holds through the next catalyst. That combination keeps it relevant as a timely candidate this week.
American Public Education (NASDAQ: APEI) is attracting momentum as improving earnings expectations keep piling up alongside persistent buying activity.
You are looking at a setup where price movement and estimate revisions are pointing in the same direction at the same time, which tends to be a sturdier foundation than either signal alone. Trading participation has stayed consistent rather than spiking randomly, which helps confirm that interest is building rather than flaring up and fading.
As both the outlook and the price behavior keep reinforcing each other, the stock stands out as a candidate for further follow-through this week.
MPLX LP (NYSE: MPLX) is worth a look this week as valuation and positioning have started to diverge from what the broader energy space has been doing.
The pullback creates a contrast worth noting when you compare it against peers that have shown more strength over the same stretch. Valuation sits below typical industry levels while earnings expectations continue adjusting to reflect evolving business conditions.
Distribution stability and midstream cash flow characteristics keep anchoring the story even when near-term sentiment stays mixed.
That combination of discounted positioning and shifting expectations keeps it relevant for anyone tracking income-supported setups this week.
Market Shift (Sponsored)
Rising geopolitical tensions have pushed oil sharply higher — and renewed focus on energy equities.
For investors, the key question is which companies could thrive if prices remain elevated.
Zacks’ latest report reviews three oil stocks worth attention in this environment.
Fast Movers to Watch
Hudson Pacific Properties (NYSE: HPP) is in a phase where patience is doing most of the work, with fair value resets reflecting a slower recovery in office and studio fundamentals.
Mixed outlooks and cautious revisions point to limited near-term momentum, even as studio leasing and portfolio repositioning keep building a longer runway. This is a name that lacks strong immediate drivers but still carries the potential for a more constructive setup as visibility gradually improves.Universal Logistics Holdings (NASDAQ: ULH) is not generating much day-to-day noise, but its valuation profile and earnings outlook suggest more substance than current sentiment reflects.
Discounted pricing paired with steady fundamentals points to a business that can earn more recognition gradually as conditions stabilize. This is a name with limited near-term excitement but a setup that could improve as value becomes harder to overlook.
nCino (NASDAQ: NCNO) is gaining renewed interest as improving growth expectations and recent execution begin reshaping how the market thinks about its trajectory. The move toward stronger revenue visibility and closer proximity to profitability suggests a business building a more durable foundation over time.
This is not a headline-grabbing name daily, but the underlying progress points to a setup that becomes more compelling as future results keep aligning with expectations.
What's your go-to metric for spotting an undervalued stock?
Everything Else
Brown-Forman shares surged more than 12% after privately held Sazerac approached the Jack Daniel’s maker about a potential deal, adding a rival bid to ongoing merger talks with Pernod Ricard.
Constellation Brands reported Q4 adjusted EPS of $1.90, beating estimates of $1.72, with revenue of $1.92 billion also topping expectations on steady Mexican beer demand.
American Airlines raised checked bag fees by $10 for the first and second bags on domestic and short-haul international flights, as jet fuel costs surged to around $209 per barrel.
Chevron forecast Q1 upstream earnings to rise between $1.6 billion and $2.2 billion versus Q4 2025, driven by surging oil prices tied to the Iran war, though hedging effects are expected to weigh on overall results.
That's our coverage for today; thanks for reading! Reply to this email with feedback or any value names you'd like us to dig into.
Best Regards,
—Noah Zelvis
Undervalued Edge
